Glymphatic clearance mechanisms were strongly associated with AQP4 (Yin et al., 2018), and deletion of AQP4 in AD transgenic mice resulted in increased Aβ burden and exacerbated cognitive impairment (Rasmussen et al., 2018). Here, AQP4 is linked to Alzheimer disease.